| Primary |
| Product Used For Unknown Indication |
23.7% |
| Sinusitis |
13.4% |
| Upper Respiratory Tract Infection |
8.3% |
| Urinary Tract Infection |
7.9% |
| Drug Use For Unknown Indication |
6.7% |
| Pneumonia |
5.5% |
| Pyrexia |
4.0% |
| Respiratory Tract Infection |
3.6% |
| Thrombosis Prophylaxis |
3.6% |
| Prophylaxis |
3.2% |
| Ear Infection |
2.8% |
| Infection |
2.8% |
| Anaesthesia |
2.4% |
| Pharyngitis |
2.4% |
| Cough |
2.0% |
| Renal Failure Chronic |
2.0% |
| Bronchitis |
1.6% |
| Pharyngitis Bacterial |
1.6% |
| Post Procedural Complication |
1.6% |
| Acute Sinusitis |
1.2% |
|
| Vomiting |
27.3% |
| Drug Ineffective |
9.1% |
| Toxic Epidermal Necrolysis |
9.1% |
| Pyrexia |
5.1% |
| Rash |
5.1% |
| Urticaria |
5.1% |
| Hepatic Failure |
4.0% |
| Swelling Face |
4.0% |
| Anaphylactic Shock |
3.0% |
| Drug Interaction |
3.0% |
| Kounis Syndrome |
3.0% |
| Rash Pruritic |
3.0% |
| Respiratory Arrest |
3.0% |
| Throat Irritation |
3.0% |
| Urinary Tract Infection |
3.0% |
| Abdominal Pain |
2.0% |
| Choking |
2.0% |
| Diarrhoea |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Dyspnoea |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
27.7% |
| Hiv Infection |
8.7% |
| Pyrexia |
8.2% |
| Mycobacterium Avium Complex Infection |
7.2% |
| Asthma |
5.6% |
| Lyme Disease |
5.6% |
| Pharyngitis Streptococcal |
4.1% |
| Sinusitis |
4.1% |
| Prophylaxis |
3.6% |
| Hypertension |
3.1% |
| Anaesthesia |
2.6% |
| Cough |
2.6% |
| Ill-defined Disorder |
2.6% |
| Pain |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Upper Respiratory Tract Infection |
2.6% |
| Respiratory Distress |
2.1% |
| Atrial Fibrillation |
1.5% |
| Bronchopneumonia |
1.5% |
| Ear Infection |
1.5% |
|
| Toxic Epidermal Necrolysis |
23.9% |
| Vaginal Haemorrhage |
8.7% |
| Clostridium Difficile Colitis |
6.5% |
| Drug Hypersensitivity |
6.5% |
| Pneumonia |
6.5% |
| Urinary Tract Infection |
6.5% |
| Drug Resistance |
4.3% |
| Thrombocytopenia |
4.3% |
| Upper Respiratory Tract Infection |
4.3% |
| Vomiting |
4.3% |
| Weight Decreased |
4.3% |
| Abdominal Pain |
2.2% |
| Chest Pain |
2.2% |
| Choking |
2.2% |
| Clostridial Infection |
2.2% |
| Confusional State |
2.2% |
| Diverticulitis |
2.2% |
| Dyspnoea |
2.2% |
| Gastrointestinal Haemorrhage |
2.2% |
| Haemolysis |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.5% |
| Drug Use For Unknown Indication |
17.1% |
| Hypertension |
6.0% |
| Pain |
3.9% |
| Anxiety |
2.7% |
| Asthma |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Pyelonephritis Acute |
2.7% |
| Depression |
2.5% |
| Contraception |
2.4% |
| Metastases To Bone |
2.4% |
| Non-small Cell Lung Cancer |
2.4% |
| Insomnia |
2.3% |
| Rheumatoid Arthritis |
2.0% |
| Pulmonary Arterial Hypertension |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Urinary Tract Infection |
1.6% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Cystic Fibrosis |
1.3% |
| Nocardiosis |
1.3% |
|
| Vomiting |
10.7% |
| Pain In Extremity |
9.5% |
| Pulmonary Embolism |
9.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.0% |
| Pyrexia |
6.0% |
| Sinusitis |
6.0% |
| Vertebroplasty |
6.0% |
| Pain |
4.8% |
| Wheezing |
4.8% |
| Deep Vein Thrombosis |
3.6% |
| Dehydration |
3.6% |
| Herpes Zoster |
3.6% |
| Kidney Transplant Rejection |
3.6% |
| Muscle Spasms |
3.6% |
| Myocardial Infarction |
3.6% |
| Oral Candidiasis |
3.6% |
| Renal Failure Acute |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Abdominal Pain |
2.4% |
| Allergic Granulomatous Angiitis |
2.4% |
|
| Interacting |
| Atrial Fibrillation |
30.0% |
| Product Used For Unknown Indication |
30.0% |
| Gout |
10.0% |
| Hypertension |
10.0% |
| Pneumonia |
10.0% |
| Renal Failure Chronic |
10.0% |
|
| Blood Creatinine Increased |
66.7% |
| Oliguria |
33.3% |
|
